Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC Cobimetinib 934660-93-2 10mM (in 1mL DMSO)
SDP

Supplier:  Apexbio Technology LLC A33215.1

Encompass_Preferred

Cobimetinib (CAS 934660-93-2) is a selective small molecule inhibitor targeting mitogen-activated protein kinase kinase (MEK) MEK functions as a kinase that specifically phosphorylates serine/threonine and tyrosine residues playing a critical role in the MAPK signaling cascade and modulating cell proliferation survival migration differentiation and angiogenesis Cobimetinib effectively inhibits MEK with an IC50 value of 0 9 nM demonstrating potent activity in various experimental cancer models including breast cancer cells harboring KRAS and B-RAF mutations In xenograft mouse models it exhibits dose-dependent tumor growth suppression and sustained inhibition of ERK phosphorylation Cobimetinib is currently evaluated in phase I clinical trials as an anticancer therapeutic candidate

Catalog No. 50-000-64393


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.